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Identification of a gene signature associated with 
elevated bone formation rate in aging mice
Krista Jackson, Aaron Hudnall, Jonathan W. Lowery
Division of Biomedical Science, Marian University College of Osteopathic Medicine, Indianapolis, Indiana
Zones 35 Weeks of Age 55 Weeks of Age
Zone 1: 18677 genes Unchanged Unchanged
Zone 2: 65 genes Up-regulated Not Detected
Zone 3: 53 genes Down-regulated Not Detected
Zone 4: 1125 genes Not Detected Up-regulated
Zone 5: 53 genes Not Detected Down-regulated
Zone 6: 64 genes Up-regulated Up-regulated
Zone 7: 9 genes Down-regulated Down-regulated
Zone 8: 1676 genes Unchanged Not Detected
Zone 9: 2643 genes Not Detected Unchanged
Zone 10: 3355 genes Unchanged Up-regulated
Zone 11: 103 genes Unchanged Down-regulated
Zone 12: 142 genes Up-regulated Unchanged
Zone 13: 148 genes Down-regulated Unchanged
Zone 14: 49 genes Down-regulated Up-regulated
Zone 15: 4 genes Up-regulated Down-regulated
35 Weeks of Age 55 Weeks of Age
Unchanged 24336 genes 21766 genes
Up-regulated 334 genes 4620 genes
Down-regulated 310 genes 201 genes
Not Detected in Control 349 genes 1387 genes
Not Detected in Mutant 355 genes 104 genes
A B
Figure 1. A: Bmpr2 mutant mice were generated by crossing Bmpr2fl/fl; Prx1-Cre+ males with Bmpr2fl/fl females. Volumetric bone
mineral density (vBMD) was quantified by micro-CT in females at 15 and 55 weeks of age. Mean decline in mg hydroxyapatite per
cubic centimeter for each genotype between 15 and 55 week old cohorts is indicated (mg HA/ccm); gray bars denote 95%
confidence intervals. B: Quantification of the bone formation marker PINP in sera of control and Bmpr2 mutant mice using ELISA.
Individual samples are represented by circles and group mean by horizontal lines ± SEM; p values determined by unpaired t test.
Osteoporosis, a disease of low bone mass that results from bone resorption exceeding bone
formation, places individuals at enhanced risk for fracture, disability, and death. There is an urgent and
unmet need for novel targets in treating osteoporosis, requiring a better understanding of the
endogenous mechanisms regulating bone formation. We reported that deletion of the Bmpr2 gene in
skeletal progenitor cells of mice causes substantially elevated bone mass in young adulthood due to
increased bone formation rate (Lowery et al, 2015). As yet unpublished work indicates the age-related
decline in bone mass of Bmpr2 mutant mice is reduced approximately three-fold compared to control
mice; quantification of serum bone turnover markers indicates this is caused by a sustained increase in
bone formation rate to at least 35 weeks of age with no alteration in bone resorption. Here, we
determine the gene signature associated with elevated bone formation rate using genome-wide
transcriptome profiling in bones of 35-week-old control and Bmpr2 mutant mice. Applying stringent
criteria comparing the expression data to eight well-accepted housekeeping genes (Ppib, Gapdh, Hprt,
Tbp, Ppia, GusB, Prkg1, and Ywhaz), we found that, out of 24,980 exon-containing transcripts detected
in both genotypes, 334 genes were up-regulated and 310 were down-regulated at least two-fold
compared to controls. An additional 704 genes were detected in only one genotype. We refined this
putative signature by performing transcriptome profiling in these animals at 55 weeks of age when
bone formation rate is no longer elevated. This revealed that, of those genes altered at 35 weeks of
age, 461 (71.5%) were either no longer up-regulated or down-regulated in Bmpr2 mutant mice by 55
weeks of age. Bioinformatic analyses on this refined gene set indicates that elevated bone formation
rate in Bmpr2 mutant mice correlates with enrichment for genes containing binding sites for
transcription factors associated with skeletal homeostasis, including FOXP1, SOX2, EGR1, E2F1, KLF4,
CNOT3, STAT4, and FOXA1. Further, several genes corresponding with osteoblast differentiation and
activity, such as Pak4 and Pla2g4a, the latter of which encodes cytosolic phospholipase A2 and whose
deletion causes osteopenia, are up-regulated in Bmpr2 mutant mice. Collectively, our findings provide
insight into the mechanisms regulating age-related bone loss and highlight potential targets for
therapeutic modulation of bone mass.
RNA-Seq Workflow:
1) Humerii obtained from four each control and Bmpr2 mutant 
mice at 35 weeks and 55 weeks of age
2) Marrow removed by gentle centrifugation
3) Bones homogenized and total RNA collected
4) Each genotype pooled at equal RNA amounts per mouse
5) Pooled RNA samples shipped to GENEWIZ; quality control 
performed
6) rRNA depletion and library synthesized then sequenced
7) Bioinformatics analysis using ENRICHR
Z1: 18677
Z2: 65
Z3: 53 Z4: 1125
Z5: 53
Z6: 64 Z7: 9









Figure 3: A: Results of RNA-Seq analyses at 35 and 55 weeks of age; expressed relative to control. B-C: Comparison of Bmpr2
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Figure 4: A: Example ENRICHR analysis on zone 15 genes.
Conclusions, Significance & Future Directions:
- Bmpr2 mutant mice display high bone mass in young adulthood and reduced age-
related bone loss.
- Genome-wide transcriptome profiling of Bmpr2 mutant bones identified 461
differentially expressed genes associated with increased osteoblast activity.
- The differential gene signature is enriched for genes containing binding sites for
transcription factors associated with skeletal homeostasis. Several genes
corresponding with osteoblast differentiation and activity are up-regulated in
Bmpr2 mutant mice.
- Collectively, our findings provide insight into the mechanisms regulating age-
related bone loss and highlight potential targets for therapeutic modulation of
bone mass.
- Future studies will involve functional studies to narrow the gene signature to
those that regulate osteoblast function.
